CnPharm cuts Hyundai Bioscience voting rights stake to 9.92% from 10.10% after exchangeable bond conversion
CnPharm cut its Hyundai Bioscience stake to 11,373,439 shares from 11,546,001 as of Oct. 13. Ownership fell to 11.79% from 11.96%. * Voting rights dropped to 9,574,235 shares, or 9.92%, from 9,746,797 shares, or 10.10%. Change driven by an exchange right exercise on exchangeable bonds. Disclaimer: This news brief was c